
Universal Health (UHS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
4.1B
Gross Profit
3.7B
90.17%
Operating Income
454.8M
11.09%
Net Income
321.6M
7.85%
EPS (Diluted)
$4.80
Balance Sheet Metrics
Total Assets
14.9B
Total Liabilities
8.0B
Shareholders Equity
6.9B
Debt to Equity
1.16
Cash Flow Metrics
Operating Cash Flow
213.0M
Free Cash Flow
121.0M
Revenue & Profitability Trend
Universal Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 15.8B | 14.3B | 13.4B | 12.6B | 11.6B |
Cost of Goods Sold | 1.6B | 1.5B | 1.5B | 1.4B | 1.3B |
Gross Profit | 14.2B | 12.7B | 11.9B | 11.2B | 10.3B |
Gross Margin % | 90.0% | 89.3% | 89.0% | 88.7% | 88.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 7.7B | 7.2B | 6.9B | 6.3B | 5.7B |
Other Operating Expenses | 4.3B | 3.8B | 3.4B | 3.0B | 2.7B |
Total Operating Expenses | 12.0B | 11.0B | 10.3B | 9.3B | 8.4B |
Operating Income | 1.7B | 1.2B | 1.0B | 1.4B | 1.4B |
Operating Margin % | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% |
Non-Operating Items | |||||
Interest Income | 1.4M | 572.0K | 378.0K | 1.6M | 2.8M |
Interest Expense | 182.5M | 202.2M | 122.4M | 83.7M | 106.3M |
Other Non-Operating Income | 2.2M | -28.3M | -10.4M | 13.9M | 14.0K |
Pre-tax Income | 1.5B | 940.4M | 866.3M | 1.3B | 1.3B |
Income Tax | 334.8M | 221.1M | 209.3M | 305.7M | 299.3M |
Effective Tax Rate % | 22.4% | 23.5% | 24.2% | 23.6% | 23.9% |
Net Income | 1.2B | 719.3M | 657.0M | 987.6M | 952.8M |
Net Margin % | 7.3% | 5.0% | 4.9% | 7.8% | 8.2% |
Key Metrics | |||||
EBITDA | 2.3B | 1.7B | 1.6B | 1.9B | 1.9B |
EPS (Basic) | $17.16 | $10.35 | $9.23 | $11.99 | $11.06 |
EPS (Diluted) | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 |
Basic Shares Outstanding | 66554000 | 69321000 | 73118000 | 82519000 | 85061000 |
Diluted Shares Outstanding | 66554000 | 69321000 | 73118000 | 82519000 | 85061000 |
Income Statement Trend
Universal Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 126.0M | 119.4M | 102.8M | 115.3M | 1.2B |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 2.2B | 2.2B | 2.0B | 1.7B | 1.7B |
Inventory | 220.9M | 217.0M | 218.5M | 206.8M | 190.4M |
Other Current Assets | 291.6M | 236.7M | 198.3M | 194.8M | 138.0M |
Total Current Assets | 2.8B | 2.8B | 2.5B | 2.3B | 3.3B |
Non-Current Assets | |||||
Property, Plant & Equipment | 3.7B | 3.5B | 3.4B | 3.1B | 2.9B |
Goodwill | 7.9B | 7.9B | 7.8B | 7.9B | 7.8B |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 729.6M | 665.4M | 674.3M | 625.6M | 602.7M |
Total Non-Current Assets | 11.7B | 11.2B | 11.0B | 10.8B | 10.2B |
Total Assets | 14.5B | 14.0B | 13.5B | 13.1B | 13.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 632.0M | 614.0M | 636.6M | 658.9M | 570.5M |
Short-term Debt | 114.7M | 198.3M | 149.2M | 112.9M | 391.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 2.2B | 2.0B | 1.9B | 2.0B | 2.5B |
Non-Current Liabilities | |||||
Long-term Debt | 4.8B | 5.2B | 5.1B | 4.4B | 3.8B |
Deferred Tax Liabilities | - | - | - | 0 | 5.6M |
Other Non-Current Liabilities | 655.8M | 584.0M | 487.7M | 464.8M | 458.5M |
Total Non-Current Liabilities | 5.5B | 5.8B | 5.6B | 4.9B | 4.6B |
Total Liabilities | 7.7B | 7.8B | 7.5B | 6.9B | 7.1B |
Equity | |||||
Common Stock | 650.0K | 672.0K | 710.0K | 771.0K | 851.0K |
Retained Earnings | 7.4B | 6.8B | 6.5B | 6.6B | 6.7B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 6.8B | 6.2B | 6.0B | 6.2B | 6.4B |
Key Metrics | |||||
Total Debt | 5.0B | 5.4B | 5.3B | 4.6B | 4.2B |
Working Capital | 605.9M | 798.0M | 622.9M | 279.4M | 800.8M |
Balance Sheet Composition
Universal Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.2B | 719.3M | 657.0M | 987.6M | 952.8M |
Depreciation & Amortization | 584.8M | 568.0M | 581.9M | 533.2M | 510.5M |
Stock-Based Compensation | 99.3M | 87.7M | 85.4M | 73.7M | 65.8M |
Working Capital Changes | 138.9M | -124.1M | -391.4M | -782.5M | 782.0M |
Operating Cash Flow | 1.8B | 1.1B | 790.8M | 720.5M | 2.2B |
Investing Activities | |||||
Capital Expenditures | -943.8M | -743.1M | -734.0M | -855.7M | -731.3M |
Acquisitions | -18.7M | -3.7M | -20.2M | -105.3M | -54.8M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -924.0M | -722.6M | -742.2M | -935.5M | -777.9M |
Financing Activities | |||||
Share Repurchases | -670.8M | -547.4M | -832.9M | -1.2B | -206.7M |
Dividends Paid | -53.3M | -55.5M | -58.4M | -65.9M | -17.3M |
Debt Issuance | 2.2B | 185.1M | 705.3M | 3.3B | 801.6M |
Debt Repayment | -2.6B | -85.5M | -89.4M | -3.0B | -962.6M |
Financing Cash Flow | -1.1B | -493.9M | -318.4M | -1.1B | -384.9M |
Free Cash Flow | 1.1B | 524.7M | 262.0M | 28.0M | 1.6B |
Net Change in Cash | -274.8M | -83.7M | -269.8M | -1.3B | 1.0B |
Cash Flow Trend
Universal Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
9.62
Forward P/E
10.05
Price to Book
1.65
Price to Sales
0.71
PEG Ratio
0.36
Profitability Ratios
Profit Margin
7.66%
Operating Margin
11.68%
Return on Equity
18.79%
Return on Assets
7.81%
Financial Health
Current Ratio
1.29
Debt to Equity
70.09
Beta
1.24
Per Share Data
EPS (TTM)
$18.97
Book Value per Share
$110.47
Revenue per Share
$251.82
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
uhs | 11.6B | 9.62 | 1.65 | 18.79% | 7.66% | 70.09 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
Encompass Health | 12.3B | 23.81 | 5.40 | 24.72% | 9.22% | 86.97 |
DaVita | 9.8B | 13.45 | 6.68 | 57.94% | 6.35% | 825.19 |
Ensign Group | 9.6B | 30.10 | 4.72 | 17.54% | 7.00% | 100.93 |
Financial data is updated regularly. All figures are in the company's reporting currency.